Market Share of Kidney Cancer Therapeutics and Diagnostics Industry
The kidney cancer therapeutics and diagnostics market is slightly consolidated in nature. There has been a presence of a considerable number of companies that are significantly contributing to the market growth. Product innovation and ongoing R&D activities to develop advanced technologies have helped boost the growth of the market. Some of the key players are Abbott Laboratories, Amgen Inc., Bayer AG, Bristol-Myers Squibb, F. Hoffmann-La Roche, Merck & Co., Inc., and others.
Kidney Cancer Therapeutics & Diagnostics Market Leaders
-
Amgen Inc.
-
Bayer AG
-
F. Hoffmann-La Roche
-
Bristol Myers Squibb
-
Abbott Laboratories
*Disclaimer: Major Players sorted in no particular order
